Protocadherin20 Acts as a Tumor Suppressor Gene: Epigenetic Inactivation in Nasopharyngeal Carcinoma.
about
PCDH18 is frequently inactivated by promoter methylation in colorectal cancer.PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance.Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease RecurrenceTargeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinomaProtocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer.Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma.Regulation of Wnt signaling by protocadherins.Aberrant expression and functions of protocadherins in human malignant tumors.A meta-analysis of glutathione S-transferase M1 and T1 genetic polymorphism in relation to susceptibility to nasopharyngeal carcinoma.PCDH10 gene inhibits cell proliferation and induces cell apoptosis by inhibiting the PI3K/Akt signaling pathway in hepatocellular carcinoma cells.Low Expression of Protocadherin-8 Promotes the Progression of Ovarian Cancer.PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancer.PCDHGA12 methylation biomarker in bronchial washing specimens as an adjunctive diagnostic tool to bronchoscopy in lung cancer.The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrestTET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells
P2860
Q33767601-FF38DEDA-E172-4235-9A7C-E55CF29DB92DQ36567898-ED57B387-977E-459C-B43E-8C47076C1224Q36712351-12B83024-8591-4D0A-ABA2-8376D722D935Q37215530-DE4F0F27-41E4-40BB-8844-64ABE8EAE69DQ37588356-E4818F89-5CFE-4379-9621-F87E90BDE0E0Q37709418-DD68AECF-B98C-4DFB-BFD4-A9E5B1139564Q38642725-34D5BE22-B164-4E0B-9BEF-0944EF5ACEDCQ38905879-02D1F077-3425-477C-94DE-EAF5722F27EEQ40529566-A09D3471-8DD4-4D45-A1B7-230D1C8139EAQ41762610-73F13F26-B454-4435-9774-7FEA3A13832BQ48519675-CC926974-C0E7-4773-A128-C06CA206C805Q49950482-CF576EE4-1879-45F6-BAB2-A01862A60C08Q55440469-A50ED33D-5F32-42F4-BCA5-2744BA8219F1Q57826113-1B94E127-B089-481C-8552-8B9FEF66F3DAQ58801315-558F436A-7EB7-48C4-9CE5-53A039CD3882
P2860
Protocadherin20 Acts as a Tumor Suppressor Gene: Epigenetic Inactivation in Nasopharyngeal Carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Protocadherin20 Acts as a Tumo ...... n in Nasopharyngeal Carcinoma.
@en
type
label
Protocadherin20 Acts as a Tumo ...... n in Nasopharyngeal Carcinoma.
@en
prefLabel
Protocadherin20 Acts as a Tumo ...... n in Nasopharyngeal Carcinoma.
@en
P2093
P2860
P356
P1476
Protocadherin20 Acts as a Tumo ...... n in Nasopharyngeal Carcinoma.
@en
P2093
Biaoli Long
Guosheng Ren
Suling Hong
Tingxiu Xiang
Zhaohui Wang
P2860
P304
P356
10.1002/JCB.25135
P50
P577
2015-08-01T00:00:00Z